Thu, 18 Jun 2026 · LIVE
Updated Nov 15, 2025 · 19:59
Jharkhand News Updated Nov 15, 2025

Jharkhand Pharmacy Boost: How New IPC Partnership Enhances Medicine Safety

The Indian Pharmacopoeia Commission has partnered with Jharkhand State Pharmacy Council to enhance medicine safety across the state. This collaboration focuses on building pharmacist capacity in pharmacovigilance and adverse drug reaction reporting. Both organizations will work together to promote the National Formulary of India as a standard reference document. The partnership aims to strengthen public health systems through evidence-based pharmacy practices and medication safety initiatives.

Indian Pharmacopoeia Commission signs MoU with Jharkhand State Pharmacy Council

New Delhi, November 15

The Indian Pharmacopoeia Commission (IPC), Ghaziabad, an autonomous institution under the Ministry of Health and Family Welfare, Government of India, signed a Memorandum of Understanding (MoU) with the Jharkhand State Pharmacy Council (JSPC), on Saturday.

To strengthen collaborative efforts aimed at promoting the safe and rational use of medicines, enhancing pharmacovigilance and materiovigilance activities, and advancing patient safety initiatives across the state of Jharkhand.

The MoU was signed by Dr V Kalaiselvan, Secretary-cum-Scientific Director, IPC, and Prasanth Kumar Pandey, Registrar-cum-Secretary, JSPC, in the presence of representatives from both organisations.

Through this collaboration, IPC and JSPC will work together to build the capacity of registered pharmacists in areas related to adverse drug reaction (ADR) reporting, pharmacovigilance and materiovigilance practices, and the safe use of medicines.

The partnership envisions strengthening the utilisation of the National Formulary of India (NFI) as a standard reference document across healthcare facilities in Jharkhand and promoting its systematic use by pharmacists to support rational dispensing and safe medication practices.

It also includes coordinated efforts to organise awareness programmes for hospital and community pharmacists, support the mandatory use of the NFI in institutional pharmacy settings, and facilitate the annual observance of the National Pharmacovigilance Week in collaboration with the IPC.

This MoU is expected to enhance professional engagement, encourage wider participation in ADR reporting, and reinforce medicine safety surveillance mechanisms in the state.

IPC will provide technical guidance and expert support for these initiatives, while JSPC will coordinate with pharmacists in public and private healthcare establishments to ensure effective implementation of the agreed activities.

The collaboration between IPC and JSPC reflects a shared commitment to improving medication safety and strengthening public health systems through structured capacity-building and the promotion of evidence-based pharmacy practice.

— ANI

Reader Comments

Priya S

Finally, some concrete action on drug safety! I've seen too many cases of adverse reactions going unreported. Hope this collaboration extends to other states as well. Patient safety should be our top priority.

Rohit P

As a pharmacist from Ranchi, I welcome this partnership. The National Formulary of India is an excellent resource that many local pharmacies don't use properly. Training programs will definitely help improve our practice.

Sarah B

While this sounds promising, I hope the implementation is effective. Often such MoUs remain on paper only. There should be regular monitoring and accountability measures to ensure real impact on ground level.

Vikram M

Excellent initiative! Pharmacists are the last mile in healthcare delivery. Proper training in ADR reporting and safe medication practices will significantly improve healthcare outcomes in tribal areas of Jharkhand. 🙏

Kavya N

This collaboration is crucial for standardizing pharmacy practices across the state. Many small pharmacies in Jharkhand operate without proper guidelines. Hope this brings systematic change and better patient care.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Reader Voices

Leave a comment

Be kind. Add to the conversation. 0/50
Thank you — your comment has been submitted.
JS blocked